Get Jnc Hypertension Guidelines 2023 Pdf

Based on JNC8, we considered individuals with systolic blood pressure (SBP) ≥140 mmHg or diastolic blood pressure (DBP) ≥90 mmHg as hypertensive; whereas, based on 2017 ACC/AHA, those with SBP ≥ 130 mmHg or DBP ≥ 80 mmHg [4] were considered hypertensive.

JNC 7 recommended a treatment threshold of 140/90 mm Hg regardless of age, whereas JNC 8 raises the systolic threshold at age 60. In addition, JNC 7 recommended a lower treatment threshold (130/80 mm Hg) for patients with diabetes or chronic kidney disease, but JNC 8 does not.

In agreement with its predecessor, JNC VI defines hypertension as systolic blood pressure (SBP) of 140 mm Hg or greater, diastolic blood pressure (DBP) of 90 mm Hg or greater, or taking a medication for hypertension.

At the completion of this vigorous process the JNC 8 report was released in December 2013.

Patients should be treated to a target systolic pressure of less than 150 mm Hg and a target diastolic pressure of less than 90 mm Hg. Treatment does not need to be adjusted if it results in a systolic pressure lower than 140 mm Hg, as long as it is not associated with adverse effects on health or quality of life.

ing to JNC 7, the general BP goal is to lower systolic BP to less than 140 mm Hg and diastolic BP to less than 90 mm Hg. This recommendation is supported by many clinical trials. A more aggressive goal of less than 130/80 mm Hg is advised for patients with diabetes or chronic kidney disease.

JNC 7 recommended a treatment threshold of 140/90 mm Hg regardless of age, whereas JNC 8 raises the systolic threshold at age 60. In addition, JNC 7 recommended a lower treatment threshold (130/80 mm Hg) for patients with diabetes or chronic kidney disease, but JNC 8 does not.

JNC 8 Recommendations 2 to 5 In all persons <60 years or in persons >18 years (and either those younger or older than 60 years with either diabetes or CKD), initiate pharmacologic treatment to lower SBP ≥140 or DBP ≥90 mm Hg and treat to a goal BP of <140/90 mm Hg.